Spots Global Cancer Trial Database for gastric cancer
Every month we try and update this database with for gastric cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Feasibility Study of Phototherapy System to Treat H Pylori | NCT00306280 | Helicobacter Py... | Phototherapy | 18 Years - 90 Years | LumeRx | |
| The Effect of Dexmedetomidine During Opioid Free Anesthesia on Postoperative Recovery After Gastrectomy | NCT04529135 | Gastric Cancer | Dexmedetomidine Remifentanil | 19 Years - 75 Years | Gangnam Severance Hospital | |
| FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer | NCT02485834 | Adenocarcinoma ... Gastric Adenoca... Gastric Cancer | FDG-PET surgery 5-FU capecitabine docetaxel Irinotecan 3D-CRT IMRT | 18 Years - | Alliance for Clinical Trials in Oncology | |
| "The Impact of Immunonutrition on Gut Microbiota-related Aspects in Colorectal Cancer and Gastric Cancer Patients" | NCT04980950 | Gastric Cancer Colorectal Canc... | Impact Oral Nes... | 18 Years - 80 Years | Medical University of Gdansk | |
| Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection | NCT02572050 | Gastric Cancer | Distal Gastrect... | 19 Years - | National Cancer Center, Korea | |
| High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity | NCT04500392 | Hypoxia Gastric Cancer Esophagus Cance... Polyp of Colon Colon Cancer | High-flow nasal... Regular nasal c... | 18 Years - 70 Years | RenJi Hospital | |
| Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer | NCT01558947 | Gastric Cancer | Peri-operative ... Peri-operative ... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Identification of Complete Lymph Node Removal by Application of Near Infrared Fluorescence Imaging in Laparoscopic and Robotic Gastrectomy | NCT01926743 | Gastric Cancer | Near infrared f... | 20 Years - 80 Years | Yonsei University | |
| Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer | NCT06250075 | Gastric Adenoca... Gastric Cancer Microbiome Cytokines Nutritional Sta... | Formulation wit... Non-interventio... | 18 Years - | Universidade Federal do Amazonas | |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) | NCT04198766 | Solid Tumor Non-Small Cell ... Melanoma Head and Neck C... Gastric Cancer Renal Cell Carc... Urothelial Carc... | INBRX-106 - Hex... Pembrolizumab 2... Pembrolizumab 4... | 18 Years - | Inhibrx, Inc. | |
| Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | NCT04882241 | Gastric Cancer Gastroesophagea... | Pembrolizumab Placebo Cisplatin Capecitabine 5-fluorouracil Docetaxel Oxaliplatin Leucovorin | 18 Years - | Merck Sharp & Dohme LLC | |
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) | NCT05104567 | Oesophageal Squ... Gastric Cancer Hepatocellular ... Colorectal Canc... Oesophageal Ade... | THOR-707 Pembrolizumab Cetuximab | 18 Years - | Sanofi | |
| Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients | NCT00738478 | Gastric Cancer | nasogastric tub... without nasogas... | 20 Years - 80 Years | Wakayama Medical University | |
| Validation of a Model for Predicting Anastomotic Leakage | NCT05646290 | Gastric Cancer | 18 Years - 85 Years | Tongji Hospital | ||
| Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer | NCT03865810 | Perioperative C... Postoperative C... Gastric Cancer | 18 Years - | Grupo Español de Rehabilitación Multimodal | ||
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | NCT00002722 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Integrated Care Pathway in Oncology (PASSION) | NCT04235556 | Colon Cancer Gastric Cancer Pancreatic Canc... Thoracic Neopla... Breast Cancer Ovarian Cancer Bladder Cancer Prostate Cancer | Care pathway un... | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease | NCT06253650 | Gastric Cancer HER2-positive G... | Experimental Control | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer | NCT02954536 | Esophageal Canc... Gastric Cancer | pembrolizumab trastuzumab capecitabine cisplatin Oxaliplatin 5-Fluorouracil | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Narrow Band Imaging for Gastric Neoplasia | NCT02197351 | Gastric Cancer Gastric Metapla... Gastric Dysplas... | White light bio... Protocolled Narrow Band Ima... | 18 Years - | University of Southern California | |
| Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | NCT03797326 | Advanced Solid ... Triple Negative... Ovarian Cancer Gastric Cancer Colorectal Canc... Glioblastoma Biliary Tract C... Pancreatic Canc... | Pembrolizumab Lenvatinib | 18 Years - | Merck Sharp & Dohme LLC | |
| Early Oral Feeding After Total Gastrectomy for Cancer | NCT01962519 | Adenocarcinoma ... | Early oral feed... | 18 Years - 80 Years | Jagiellonian University | |
| Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy | NCT01938313 | Gastric Cancer | ERAS perioperat... Conventional pe... | 20 Years - 80 Years | Seoul National University Bundang Hospital | |
| Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia | NCT05124704 | Gastric Cancer | 5-8ml 0.375% ro... 5-8ml normal sa... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| ADCC Against Gastric Cancer Cells | NCT02078362 | Gastric Cancer | 21 Years - 80 Years | National University Hospital, Singapore | ||
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | NCT04068896 | Pancreatic Canc... Metastatic Cast... Bladder Cancer Melanoma Non-small Cell ... Colorectal Canc... Gastric Cancer Esophageal Canc... Ovarian Cancer Head Neck Squam... Prostate Cancer | NGM120 NGM120 NGM120 NGM120 NGM120 NGM120 Placebo | 18 Years - | NGM Biopharmaceuticals, Inc | |
| Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies | NCT04383938 | Bladder Cancer Gastric Cancer Non Small Cell ... NSCLC Urothelial Carc... Advanced Solid ... | APR-246 (eprene... | 18 Years - | Aprea Therapeutics | |
| Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer | NCT00439608 | Esophageal Canc... Gastric Cancer | Cetuximab,Pacli... | 18 Years - | Brown University | |
| Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series) | NCT05068635 | Gastric Cancer | 15 Years - | Centre Hospitalier Universitaire Ibn Rochd | ||
| Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | NCT00183859 | Adenocarcinoma Gastric Cancer | irinotecan | 18 Years - | University of Southern California | |
| SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma | NCT03950271 | Gastric Cancer | SHR-1210 Combin... | 18 Years - 75 Years | Henan Cancer Hospital | |
| The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective Study | NCT04973631 | Sex Age Gastric Cancer | Sex, Age | - | Seoul National University Bundang Hospital | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy | NCT00358397 | Tumors | Clostridium nov... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer Surgery | NCT00757640 | Gastric Cancer | cholecystectomy | 18 Years - 80 Years | Italian Research Group for Gastric Cancer | |
| PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer | NCT05033392 | Stomach Neoplas... | Toripalimab Inj... | 18 Years - 79 Years | Shenzhen People's Hospital | |
| Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication | NCT01678027 | Gastric Cancer Helicobacter Py... Family Members | Placebo LAC triple ther... | 40 Years - 65 Years | National Cancer Center, Korea | |
| Efficacy and Safety of ESD for the Treatment of Superficial Gastric Neoplasms | NCT05930860 | Gastric Cancer | Endoscopic Subm... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours | NCT05605522 | Pancreatic Duct... Squamous Cell C... Colorectal Canc... Gastric Cancer Ewing Sarcoma NTSR1 Expressin... Neuroendocrine ... | [225]-FPI-2059 [111In]-FPI-205... | 18 Years - | Fusion Pharmaceuticals Inc. | |
| Cytosponge for Gastric Intestinal Metaplasia | NCT05657080 | Gastric Cancer Gastric Intesti... Gastric Atrophy | Cytosponge-TFF3 | 18 Years - | University of Cambridge | |
| Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer | NCT03745170 | Gastric Cancer | Sintilimab Oxaliplatin Capecitabine placebo | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer | NCT05497739 | Gastric Cancer | Intraperitoneal... Adjuvant system... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| A Survivorship Care Plan for Gynaecological Cancer Patients | NCT01582906 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
| Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study | NCT03978481 | Gastric Cancer | Helicobacter py... | 19 Years - | Seoul National University Bundang Hospital | |
| D1 vs D2 Lymphadenectomy in Gastric Cancer | NCT05253430 | Gastric Cancer | Lymphadenectomy... | 18 Years - | Fundación para la Investigación del Hospital Clínico de Valencia | |
| Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. | NCT03784040 | Gastric Cancer | OTSGC-A24 Nivolumab Ipilimumab | 21 Years - 99 Years | National University Hospital, Singapore | |
| To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. | NCT05948449 | Gastric Cancer | S-1, Oxaliplati... | 18 Years - 75 Years | Sichuan University | |
| FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | NCT04768686 | Gastric Cancer | FLX475 Pembrolizumab | 18 Years - | Hanmi Pharmaceutical Company Limited | |
| A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | NCT00123318 | Gastric Cancer | epirubicin cisplatin 5-fluorouracil Radiotherapy | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Tepotinib Plus Paclitaxel in MET Amplified or MET Exon 14 Alterated Gastric and GEJ Carcinoma | NCT05439993 | Gastric Cancer Gastroesophagea... | Tepotinib plus ... | - | Hallym University Medical Center | |
| Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric Cancer | NCT04593615 | Gastric Cancer Surgery | ICG near-infrar... | 18 Years - 75 Years | Fujian Medical University | |
| Tisseel® as a Reinforcement of Esophagojejunal Anastomoses | NCT03733639 | Gastric Cancer Anastomotic Lea... | Tisseel No Tisseel | 18 Years - | Germans Trias i Pujol Hospital | |
| Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. | NCT01924533 | Gastric Cancer | Olaparib Paclitaxel Placebo | 18 Years - 99 Years | AstraZeneca | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）for Advanced Gastric Cancer | NCT01978444 | Gastric Cancer | Laparoscopic D2... Laparoscopic D2... | 18 Years - 75 Years | Huazhong University of Science and Technology | |
| Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | NCT00210184 | Gastric Cancer | Irinotecan asso... | 70 Years - 100 Years | Institut Bergonié | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | NCT06010862 | Gastric Cancer Colon Cancer Pancreas Cancer Esophagus Cance... Cholangiocarcin... Lung Cancer Breast Cancer | CEA CAR-T cells CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| A Study of NX-1607 in Adults With Advanced Malignancies | NCT05107674 | Ovarian Cancer,... Gastric Cancer GastroEsophagea... Head and Neck S... Metastatic or U... Non-small Cell ... Metastatic Cast... Malignant Pleur... Triple Negative... Metastatic Urot... Cervical Cancer Diffuse Large B... Richter Transfo... Microsatellite ... | NX-1607 Paclitaxel | 18 Years - | Nurix Therapeutics, Inc. | |
| Perception Prognosis, Goals of Treatment, and Communication | NCT01401894 | Gastric Cancer Esophageal Canc... Pancreatic Canc... Liver Cancer Biliary Cancer | 18 Years - | Massachusetts General Hospital | ||
| Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | NCT00848783 | Gastric Cancer Gastric Adenoca... Esophageal Canc... | Irinotecan Cisplatin Surgery Floxuridine Capecitabine | 18 Years - | NYU Langone Health | |
| Apatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer | NCT03219593 | Gastric Cancer Apatinib Biomarker | Apatinib mesyla... | 65 Years - | First Affiliated Hospital Bengbu Medical College | |
| A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | NCT05860374 | Sarcoma Carcinoma Breast Cancer Pancreatic Canc... Colorectal Canc... Gastric Cancer Liver Cancer Lung Cancer Gynecologic Can... | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
| A Novel Online Calculator to Predict Long-term Survival and Recurrence Risk of Patients With Gastric Adenocarcinoma | NCT06337266 | Gastric Cancer | - | Fujian Medical University | ||
| Optimal Prophylactic Method of Venous Thromboembolism (VTE) | NCT01448746 | Venous Thromboe... | low molecular w... | 20 Years - 75 Years | The Catholic University of Korea | |
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer | NCT01291407 | Gastrointestina... Gastric Cancer | S-1 S-1 S-1 S-1 S-1 S-1 | 18 Years - 75 Years | ChineseAMS | |
| Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer | NCT05318794 | Gastric Cancer Peritoneal Meta... Chemotherapy Ef... | Doxorubicin and... | - | Imperial College London | |
| Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer. | NCT00209729 | Gastric Cancer | Taxotere TS-1 | 76 Years - 80 Years | Hokkaido Gastrointestinal Cancer Study Group | |
| Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection | NCT00464893 | Gastric Cancer Gastric Adenoca... | Catumaxomab catumaxomab | 18 Years - | Neovii Biotech | |
| Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer | NCT01795027 | Gastric Cancer | S-1 plus oxalip... S-1 single | 18 Years - 70 Years | Sun Yat-sen University | |
| A Phase 1/2 Study of BA3071 as Monotherapy and in Combination With a PD-1 Blocking Antibody in Patients With Advanced Solid Tumors | NCT05180799 | Solid Tumor, Ad... NSCLC Urothelial Carc... Gastric Cancer Small Cell Lung... Hepatocellular ... Cervical Carcin... Melanoma Renal Cell Carc... Carcinoma | BA3071 Nivolumab Pembrolizumab | 18 Years - | BioAtla, Inc. | |
| Pre- and Post-Operative Exercise Program in Upper Gastrointestinal Cancers | NCT03807518 | Exercise Interv... | Standard Exerci... | 18 Years - | Royal College of Surgeons, Ireland | |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | NCT03638206 | B-cell Acute Ly... Lymphoma Myeloid Leukemi... Multiple Myelom... Hepatoma Gastric Cancer Pancreatic Canc... Mesothelioma Colorectal Canc... Esophagus Cance... Lung Cancer Glioma Melanoma Synovial Sarcom... Ovarian Cancer Renal Carcinoma | CAR-T cell immu... | 4 Years - 70 Years | Shenzhen BinDeBio Ltd. | |
| Nutrition and Lifestyle Study Cohort of Gastric Cancer in China | NCT02216955 | Gastric Cancer | 18 Years - 90 Years | State Key Laboratory of Cancer Biology | ||
| XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | NCT01406249 | Gastric Cancer | SP XP | 20 Years - 74 Years | Epidemiological and Clinical Research Information Network | |
| Study About no Antimicrobial Prophylaxis in Totally Laparoscopic Distal Gastrectomy | NCT03802097 | Gastric Cancer Complication of... | No use of antim... Use of antimicr... | 18 Years - 75 Years | Korean South West East Gastric Surgery Group | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIs | NCT02436395 | Surgical Site I... Gastric Cancer Dehiscence of L... | Group A (povido... Group B (normal... | 18 Years - 75 Years | West China Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
